TABLE I.

Patient Demographics

Patient demographics
N	33
Median age, y (range)	61	(42–89)
Female, n (%)	9	(27.3)
DM, n (%)	5	(15.2)
CAD, n (%)	5	(15.2)
COPD/OSA/asthma, n (%)	4	(12.1)
History of smoking, n (%)	12	(36.4)
Median T stage (range)	3	(0–3)
Median N stage (range)	1	(0–2)
Median preablation CEA, ng/mL (range)	4	(0.7–9.6)
Preoperative chemotherapy, n (%)	32	(97)
Patients with concurrent procedure, n (%)	28	(84.8)
Hepatic resection, n (%)	23	(69.7)
Postoperative chemotherapy, n (%)	30	(90.9)